Vaccines based on whole recombinant Saccharomyces cerevisiae cells.
Vaccines based on whole recombinant Saccharomyces cerevisiae cells.
复制标题
DOI：
10.1111/j.1567-1364.2010.00665.x
复制
发表时间：
2010-12
影响因子：
3.2
通讯作者：
Hodge JW
中科院分区：
文献类型：
--
作者：
Ardiani A;Higgins JP;Hodge JW
The ultimate goal of therapeutic vaccines is to activate and exploit the patient’s own immune system to vigorously and dynamically seek and eradicate established malignant or virally infected cells. Therapeutic vaccines also offer the potential for preventing disease recurrence. Saccharomyces cerevisiae-based vaccines, where the yeast is engineered to express viral or tumor antigens, represent an ideal therapeutic approach due to their ability to stimulate tumor- or viral-specific CD4+ and CD8+ T-cell responses that are capable of reducing disease burden. This review describes preclinical and clinical studies supporting the development of S. cerevisiae-based therapeutic vaccines for the treatment of cancer and viral diseases, as well as multimodal strategies in which therapeutic vaccines are combined with cytotoxic drugs to achieve a greater clinical response.
登录
查看更多内容
影响因子：
4.4
作者：
Burke KP;Cox AL
通讯作者：
Cox AL
影响因子：
6.2
作者：
Higano, Celestia S.;Schellhammer, Paul F.;Frohlich, Mark W.
通讯作者：
Frohlich, Mark W.
影响因子：
3.6
作者：
Higgins JP;Bernstein MB;Hodge JW
通讯作者：
Hodge JW
影响因子：
11.5
作者：
Chakraborty, Mala;Wansley, Elizabeth K.;Hodge, James W.
通讯作者：
Hodge, James W.
影响因子：
--
作者：
Heintel, T;Breinig, F;Meyerhans, A
通讯作者：
Meyerhans, A